No Data
No Data
Daan gene co.,ltd. (002030.SZ) has obtained two medical instruments registration certificates.
daan gene co.,ltd. (002030.SZ) announced that the company has recently obtained the medical... issued by the National Medical Products Administration.
Daan Gene: Report for the third quarter of 2024
daan gene co.,ltd. (002030.SZ) released its performance for the first three quarters, with a net loss of 0.503 billion yuan.
daan gene co.,ltd. (002030.SZ) released the third quarter report of 2024, the company's revenue in the first three quarters was 5...
Daan Gene's Unit Gets Registration Certificate for Alpha-Fetoprotein Kit
daan gene co.,ltd. (002030.SZ) subsidiary has obtained a medical instruments registration certificate.
daan gene co.,ltd. (002030.SZ) announced that its wholly-owned subsidiary, Guangzhou Datai Biotechnology Engineering Technology Co., Ltd...
daan gene co.,ltd. (002030.SZ): The wholly-owned subsidiary received a cash dividend of 0.4634 million yuan.
Gelonghui, September 26th, daan gene co.,ltd. (002030.SZ) announced that its wholly-owned subsidiary, Guangzhou Daan Gene Technology Co., Ltd. (hereinafter referred to as "Daan Technology"), recently received cash dividends from its shareholding company, Zhuhai Yasha Biotechnology Co., Ltd. (hereinafter referred to as "Yasha Company"), as follows: According to the resolution of Yasha Company's 2024 third interim shareholders' meeting, the profit distribution plan is as follows: based on the existing total share capital of 41,927,609 shares, each shareholder will receive 1.2 RMB cash for every 10 shares. Daan Technology, a wholly-owned subsidiary of the company, holds a stake in Yasha Company
No Data
No Data